Published in Lab Business Week, July 17th, 2005
CytRx was notified in February 2004 that the Massachusetts Commission had initiated a preliminary inquiry into whether the company's previous retention of a consultant who introduced the company to the University of Massachusetts Medical School (UMMS) constituted an improper conflict of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.